T he Rho GTPases are critical modulators of cell morphology and motility through their regulation of the actin cytoskeleton. The activation state of Rho GTPases is governed by the balance between the activities of GTPaseactivating proteins, which catalyse hydrolysis of guanosine-5 0 -triphosphate (GTP) and guanine exchange factors (GEFs), which promote GTP binding. GEF-H1, also known as ARHGEF2 or Lfc in mouse, is associated with microtubules in its inactive state 1 . Expression of GEF-H1 promotes stress fibre formation through RhoA activation, while its depletion attenuates actin reorganization [2] [3] [4] [5] . A mutant of GEF-H1 unable to bind to microtubules has increased GEF activity and induces stress fibre formation 5 , suggesting that GEF-H1 is a critical factor mediating crosstalk between microtubules and actin 5 . We have shown that the dynein light-chain Tctex-1 tethers GEF-H1 to polymerized microtubules 6 , where it is poised to undergo D-AKAP-1-dependent phosphorylation of Ser885 by PKA. Phosphorylation of Ser885 creates a high-affinity 14-3-3-binding site that inhibits the exchange activity of GEF-H1 (ref. 3) . Nocodazole-induced depolymerization of microtubules disrupts this inhibited GEF-H1 complex resulting in potent activation of GEF-H1, suggesting that cycles of microtubule depolymerization under physiologic conditions would release GEF-H1, providing local and temporally constrained activation of RhoA 6, 7 .
We and others have shown that a variety of receptor ligands including lysophosphatidic acid (LPA) 3 , thrombin 2 , tumour necrosis factor-a and epidermal growth factor 8, 9 lead to activation of GEF-H1 through unknown mechanisms. Moreover, GEF-H1 can be activated by mechanotransduction through an integrin-mediated mechanism, which is suggested to be independent of microtubule depolymerization 10 .
In the present study, we sought to determine the mechanism underlying GEF-H1 activation in response to the GPCR (Gprotein-coupled receptor) ligands LPA and thrombin. Ga 12/13 proteins play a well-established role in the activation of RhoGEFs belonging to the regulator of G-protein signalling (RGS) domaincontaining RhoGEF subfamily, which includes p115-RhoGEF, PDZ-RhoGEF, leukemia-associated RhoGEF (LARG) and possibly Lbc-RhoGEF [11] [12] [13] . Ga 12/13 subunits bind directly to the RGShomology (RH) domain contained within the polypeptide sequences of these GEFs, which is thought to alleviate autoinhibition of their exchange activity. Although GEF-H1 is known to respond to Ga 12/13 -coupled GPCR stimulation, to date no interaction with Ga 12/13 has been shown, nor has an RH domain been identified in its polypeptide sequence.
Here we identify a novel mechanism for GEF-H1 activation mediated by the coincident interaction of Ga 12/13 with GEF-H1 and Gbg with Tctex-1, resulting in the release and activation of GEF-H1 from the inhibitory dynein-associated complex. In addition, we show that thrombin stimulates the interaction between PP2A and GEF-H1 triggering dephosphorylation of Ser885, which is required for activation. This study provides a detailed multistep mechanism for GPCR-mediated activation of GEF-H1 independent of microtubule depolymerization.
Results

LPA/thrombin induce GEF-H1 release from intact microtubules.
GEF-H1 is required for LPA/thrombin-induced stress fibre formation, and focal adhesion formation following stimulation with tumour necrosis factor-a, LPA or thrombin 2, 3, 6 . We have recently shown that microtubule-dependent inhibition of GEF-H1 requires the assembly of a protein complex including Tctex-1, dynein intermediate chain (DIC) and 14-3-3 proteins 6 . We examined whether the microtubule-associated inhibited GEF-H1 complex is altered following LPA or thrombin stimulation, and observed that 5 min following treatment with LPA or thrombin, the stoichiometry of DIC, 14-3-3 and Tctex-1 present in GEF-H1 immune complexes markedly decreased compared with basal conditions (Fig. 1a) .
Dissolution of the interaction between DIC-Tctex-1 and GEF-H1 might represent one mechanism by which growth factor stimulation could activate GEF-H1 by displacement from the microtubule array. We investigated whether LPA or thrombin stimulation alters GEF-H1 localization. GEF-H1-knockout murine embryonic fibroblasts (MEFs) were transfected with GEF-H1-enhanced green fluorescent protein (eGFP) and visualized by confocal microscopy before and after treatment. In untreated cells, GEF-H1-eGFP was closely associated with the microtubule array (correlation coefficient of 0.67, n ¼ 91), whereas after 5 min of LPA or thrombin treatment GEF-H1-eGFP moved into a largely cytoplasmic distribution (Fig. 1b-d ). Similar to GEF-H1 localization after application of force 10 , we noted that a fraction of GEF-H1 relocalized to vinculin-positive focal adhesion structures following treatment with LPA (correlation coefficient of 0.81, n ¼ 74) ( Fig. 1e; Supplementary Fig. 1 ). Importantly, acute treatment with LPA or thrombin did not depolymerize the microtubule network, suggesting that under these conditions GEF-H1 displacement was not contingent on disruption of microtubule arrays (Fig. 1c) . To address the possibility that growth factor stimulation of cells increased microtubule dynamics, which may not be observable under steady-state conditions, we visualized live cells expressing cherry tubulin and GEF-H1-eGFP using real-time confocal microscopy. Live imaging verified that the bulk of the microtubule array remained intact during the time interval of the stimulation coincident with GEF-H1 relocalization into the cytoplasm (Fig. 1f) .
The Gb subunit binds to Tctex-1 and activates GEF-H1. LPA and thrombin signal to cells through activation of the LPA receptors and protease-activated GPCRs, respectively. Inactive GPCRs associate with a-, b-and g-subunits (known as Ga, Gb and Gg, respectively), however, upon ligand activation, the Ga subunit dissociates from the Gbg heterodimer, where upon both subunits can engage multiple intracellular signalling pathways.
Sachdev et al. 15 showed that the Gb subunit binds to Tctex-1 and competes with DIC for binding to Tctex-1, regulating assembly of Tctex-1 into the dynein motor complex 14, 15 . We asked whether Gbg subunits might impinge on the GEF-H1:Tctex-1:dynein complex, leading to the displacement of GEF-H1 from microtubules and its activation. We confirmed that Gb bound to Tctex-1 in 293T cells co-expressing Gb 12 isoform, Tctex-1 and GEF-H1, while a Gb variant (Gb mut ) bearing three mutations (R48A, R49A and R52A) in the Tctex-1-binding site pulled down significantly less Tctex-1 (Fig. 2a) , consistent with results reported by Sachdev et al. 15 To determine whether Gb binding to Tctex-1 disrupts the interaction between GEF-H1 and Tctex-1, GEF-H1 immune complexes were analysed for the presence of Tctex-1 in the absence or presence of the expressed Gb 12 subunit. While Tctex-1 was detected in GEF-H1 immunoprecipitates, expression of Gb markedly reduced the association of GEF-H1 with Tctex-1 protein (Fig. 2b) . The specificity of this effect was demonstrated by the observation that Gb mut expression did not alter the GEF-H1:Tctex-1 interaction (Fig. 2b) . These data suggest that the Gb subunit can disrupt the anchoring function of Tctex-1 that links GEF-H1 to microtubules. We therefore examined whether Gb 12 g 12 expression could alter GEF-H1 localization to the microtubule array using fluorescence microscopy. We observed that the localization of GEF-H1-eGFP, normally intimately associated with the microtubule array, redistributed into a diffuse pattern in cells expressing the Gbg subunits ( Fig. 2c; Supplementary  Fig. 2a) . To demonstrate the specificity of the Gbg effect on GEF-H1 redistribution, we co-expressed the Gbg-specific antagonist peptide, bARKct, derived from the Gbg-binding domain of b-adrenergic receptor kinase 1, which specifically inhibits Gbg-dependent signalling 16 , and noted that coexpression of bARKct restored GEF-H1-eGFP localization to the microtubules ( Fig. 2c; Supplementary Fig. 2a ). We next queried whether Gbg expression could induce stress fibre formation in a GEF-H1-dependent manner following the redistribution of GEF-H1 from the microtubule array. We found that expression of the Gbg subunits was sufficient to induce actin-based stress fibres in wild-type MEFs but not in GEF-H1 knockout MEFs (Fig. 2d) , reinforcing the idea that Gbg plays a role in inducing stress fibre formation through GEF-H1. Last, we investigated whether expression of Gbg could regulate the catalytic activity of GEF-H1. As previously reported, Tctex-1 potently inhibited the exchange activity of full-length GEF-H1 (refs 6,17) , whereas co-expression of the Gbg subunits relieved this inhibitory effect (Fig. 2e) . In contrast, expression of the Gb mut peptide was unable to antagonize the inhibitory effect of Tctex-1 ( Fig. 2e; Supplementary Fig. 2b ). Co-expression of the bARKct inhibitory peptide blocked the ability of Gbg to antagonize Tctex-1-mediated inhibition of GEF-H1 ( Fig. 2e ; Supplementary Fig. 2b ), demonstrating the specificity of the Gbg effect. These data demonstrate that Gbg can disrupt the interaction of GEF-H1 with the dynein motor complex leading to its displacement from the microtubule array and activation of its exchange activity. Fig. 3a; Supplementary Fig. 3 ). The requirement of GEF-H1 for stress fibre formation suggested that this aspect of Ga 12/13 signalling operates through the GEF-H1 pathway. We next examined whether constitutively active Ga 12 or Ga 13 could trigger a change in GEF-H1 localization and stimulate GEF-H1 activation. GEF-H1 À / À cells were transfected with GEF-H1-eGFP alone or together with a constitutively active Ga 12/13 mutant (Ga 12QL, Ga 13QL ), fixed and stained with phalloidin or anti-tubulin antibodies. GEF-H1-eGFP localized to microtubules in starved cells that contained little polymerized actin ( Fig. 3b,c; Supplementary Fig. 3 ). Expression of Ga 12QL or Ga 13QL induced the redistribution of GEF-H1-eGFP from the microtubule array to a diffuse cytoplasmic pattern and was associated with stress fibre formation ( Fig. 3b,c ; Supplementary  Fig. 3 ), both of which were blocked by the co-expression of the RGS domain of p115 (rgRGS), which specifically binds and blocks Ga 12/13 (refs 18,19) . This demonstrates that the RH domainbinding surface of Ga 12QL is required to regulate GEF-H1 redistribution from the microtubules.
The Ga subunit binds directly to GEF-H1. To determine whether activation of GEF-H1 by Ga 12/13 is mediated by a direct binding event, we performed pull-down experiments with purified recombinant Ga 13 (a chimera of Ga i1 residues 1-28 fused to Ga 13 residues 41-377 (ref. 20) ) and GEF-H1 proteins. Recombinant full-length GEF-H1 protein expressed and purified from insect cells 6 bound to recombinant Ga 13 , indicating that active Ga can bind directly to GEF-H1 in vitro ( Supplementary  Fig. 4a ). A series of GEF-H1 truncations and deletions revealed that the Ga 12/13 -binding site resides in the N-terminal region of GEF-H1 ( Fig. 4a ; Supplementary Fig. 4b ). Coimmunoprecipitation experiments with a series of Flag-tagged, N-terminal expressed GEF-H1 fragments demonstrated that amino acids 1-240 of GEF-H1 are sufficient for optimal binding to endogenous Ga 12 while shorter deletions within this region markedly reduced Ga binding (Fig. 4b) . The requirement 
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Phalloidin Gα12 for the entire 240-a.a. N terminus of GEF-H1 for Ga binding suggests either the presence of a folded domain or several multivalent-binding sites, and is consistent with the size of RH domains of p115, PDZ and LARG, which are 200 amino acids or greater in length. The Ga-binding site on GEF-H1 overlaps the binding site of Tctex-1. Therefore, we asked whether Ga 12/13 competes with Tctex-1 binding, and whether displacement of Tctex-1 by Ga 12/13 may contribute to the activation of GEF-H1. GEF-H1 immune complexes from HEK293T cells expressing GEF-H1, Tctex-1 and Ga 13QL were analysed for the presence of Tctex-1 and Ga 13 . While Tctex-1 was detected in GEF-H1 immunoprecipitates derived from cells expressing GEF-H1 and Tctex-1 alone, expression of Ga 13QL markedly reduced the association of Tctex-1 with GEF-H1 (Fig. 4c) . Moreover, Ga 13QL potently antagonized the inhibition of GEF-H1 exchange activity by overexpressed Tctex-1 in an rgRGS-sensitive manner (Fig. 4d) , consistent with the observation that Ga 13QL functionally competes with Tctex-1. In the absence of Tctex-1 overexpression, GEF-H1 exchange activity increased when Ga 13QL was coexpressed, however, this trend did not reach statistical significance, supporting the hypothesis that displacement of Tctex-1 is the major mechanism by which Ga 13 activates GEF-H1. Similar results were obtained for Ga 12QL .
We and others have previously shown that GEF-H1 is phosphorylated on Ser885 and associated with 14-3-3 proteins in its inactive state 3, 21 . We examined whether Ga 13QL disrupted the interaction of 14-3-3 with GEF-H1 as a surrogate measure of GEF-H1 activation. We probed the association of 14-3-3 with GEF-H1 in cells with or without Ga 13QL expression. While 14-3-3 was detected in GEF-H1 immunoprecipitates derived from GEF-H1-transfected cells, Ga 13QL co-expression markedly reduced the association of 14-3-3 proteins with GEF-H1 (Fig. 5a) . Expression of the dominant-negative rgRGS domain blocked this effect of Ga 13QL , and restored the interaction between 14-3-3 and GEF-H1 (Fig. 5a ). We next co-expressed GEF-H1 with 14-3-3 or Tctex-1 or Ga 13QL , immunoprecipitated 14-3-3, Tctex-1 or Ga 13QL and probed the status of Ser885 phosphorylation in each complex with a phospho-Ser885-specific GEF-H1 antibody. We observed that the level of GEF-H1 Ser885 phosphorylation was strongly correlated with association with 14-3-3 and Tctex-1 and inversely correlated with Ga 13 association (Fig. 5b) . These results suggest that GEF-H1 bound to Ga is in its active state (that is, dephosphorylated on Ser885).
Ga or Gb is sufficient to release GEF-H1 from microtubules.
Having demonstrated that either Gb or Ga can activate GEF-H1, we queried whether both subunits are required in vivo for stimulation of GEF-H1 by ligand-induced activation of GPCRs. Following stimulation with thrombin, GEF-H1 was immunoprecipitated from lysates of starved HEK293T cells expressing the rgRGS domain (to sequester Ga 12/13 ) 18, 19 and/or bARKct (to block Gb) 16 . The resulting immune complexes were probed for endogenous DIC as a marker of GEF-H1 localization to the microtubule-associated dynein-protein complex. While endogenous DIC was co-immunoprecipitated with Flag-GEF-H1 from starved HEK293T cells (Fig. 5c) , the amount of DIC associated with GEF-H1 was markedly reduced after 5 min treatment with thrombin (Fig. 5c) . Expression of either rgRGS or bARKct alone had little impact on thrombin's ability to disrupt the GEF-H1-DIC interaction, however, co-expression of both rgRGS and bARKct blocked the disruptive effect of thrombin on the GEF-H1-DIC complex (Fig. 5c) . In parallel experiments, we examined the localization of GEF-H1-eGFP following thrombin treatment in cells expressing the rgRGS domain or the bARKct peptide. We observed that neither the rgRGS domain nor the bARKct peptide alone were sufficient to block the relocalization of GEF-H1 by thrombin, however, the expression of both inhibitory proteins had a potent blocking effect on GEF-H1 relocalization (Fig. 5d) . These results provide evidence that either Ga or Gb is sufficient to trigger the displacement of GEF-H1 from the microtubules. Finally, we used the rgRGS domain and/ or the bARKct peptide to examine whether Gb and Ga exhibit functionally redundant or cooperative roles in the GPCRstimulated activation of GEF-H1. The inhibitory effect of Tctex-1 on GEF-H1 exchange activity was relieved by treatment of cells with LPA, and this was not impacted by expression of rgRGS or bARKct alone (Fig. 5e) . However co-expression of rgRGS and bARKct together blocked the ability of LPA to relieve Tctex-1 
GEF-H1 associates with and is dephosphorylated by PP2A.
A clue as to the identity of the phosphatase that dephosphorylates GEF-H1 Ser885 was obtained from a systematic survey of all PP2A catalytic, scaffolding and regulatory subunit interactions. In this screen, Flag-tagged components of the PP2A holoenzyme were expressed in 293 Flp-In T-REx cells, and used for affinity purification coupled to mass spectrometry. GEF-H1 was detected with several of the bait proteins in this screen (Supplementary Table I ). Spectral counts were extracted for GEF-H1 and normalized to spectral counts for the PP2A-scaffolding A subunit (PPP2R1A) to control for differences in expression of the different regulatory subunits. While GEF-H1 was readily recovered with both the catalytic and the scaffolding subunits, it only co-purified with members of one of the regulatory (B) families, the B 0 regulatory subunits PPP2R5A, PPP2R5B and PPP2R5E (Fig. 6a) , suggesting specificity in the regulatory subunit selection. We validated the interactions between GEF-H1 and the PP2A subunits by co-immunoprecipitation and showed that endogenous GEF-H1 and endogenous PP2A catalytic subunit proteins bind to one another (Fig. 6b) . Next, we confirmed the specificity in regulatory subunit selection by co-immunoprecipitation followed by immunoblotting using the stable cell lines used in Fig. 6a : Flag-tagged PP2A catalytic subunit and B 0 regulatory subunit, but not B, B 00 or B 000 subunits, each precipitated endogenous GEF-H1 (Fig. 6c) . To map the regions of GEF-H1 involved in PP2A binding, we expressed truncated variants of GEF-H1 and probed for the catalytic subunit of PP2A in GEF-H1 immune complexes (Fig. 6d) . The endogenous PP2Ac subunit was present in precipitates of full-length GEF-H1, the Dbl-homology (DH) and pleckstrin-homology (PH) domain (236-572) and the PH domain (473-572), but not in complexes formed by the DH domain alone, thus localizing the PP2Ac-binding site to the PH domain of GEF-H1 (Fig. 6d) . We sought to determine whether PP2A was the phosphatase responsible for the dephosphorylation required for GEF-H1 activation. Flag-GEF-H1 derived from starved HEK293T cells was highly phosphorylated, as determined by an antibody recognizing the phosphorylated 14-3-3-binding motif (Fig. 7a) . Immunopurified Flag-GEF-H1 was then incubated with 0.1 U of recombinant PP2A catalytic subunit or buffer control, and a time course of the phosphorylation state was followed by western blot using PPP2CA  PPP2CB  PPP2CB  PPP2R1A  PPP2R1A  PPP2R1B  PPP2R1B  PPP2R2B  PPP2R2B  PPP2R2C  PPP2R2C  PPP2R2D  PPP2R2D  PPP2R3A   PPP2 CB  PPP2R 2A  PPP2R 5A  PPP2R 5B  PPP2R 5E  PPP2R 3A  STRN3   PPP2R3A  PPP2R3C  PPP2R3C  PPP2R5A  PPP2R5A  PPP2R5B  PPP2R5B  PPP2R5D  PPP2R5D  PPP2R5E  PPP2R5E  PPP2R2A Tctex-1
GEF-H1/PPP2R1A Figure 6 | The interaction of PP2A with GEF-H1 is inducible. (a) Identification of GEF-H1 as an interaction partner with specific PP2A subunits. Spectral counts from affinity purification and mass spectrometry (AP-MS) experiments for GEF-H1 and the A subunit PPP1R1A using the catalytic (PPP2CA, PPP2CB), scaffolding (PPP2R1A, PPP2R1B) and indicated regulatory B subunits as bait. Baits are represented on the x axis with two biological replicates performed per bait. The y axis indicates GEF-H1 spectra normalized to PPP2R1A (number spectra for GEF-H1/number spectra for PPP2R1A) Â 100. Values were plotted independently for each replicate to assess the reproducibility of the measurements. (b) Endogenous GEF-H1 and endogenous catalytic subunit of PP2A interact. Wild-type MEF cells growing in DMEM 10% FBS were lysed and GEF-H1 immune complexes were probed for endogenous PP2A catalytic subunit with anti-PP2Ac antibodies. Total GEF-H1 and PP2Ac expression levels are shown. (c) GEF-H1 interacts with PP2A catalytic and B 0 subunits. Flp-In T-RexHEK293 cells, each stably expressing a distinct Flag-PP2A subunit, were lysed and PP2A subunits were immunoprecipitated with anti-Flag antibodies (row 1). PP2A subunit complexes were probed for endogenous GEF-H1 using anti-GEF-H1 antibodies (row 2). (d) PP2A binds to the pleckstrin-homology (PH) domain of GEF-H1. Flag-tagged full-length and truncated variants of GEF-H1 (DH, Dbl-homology; PH, pleckstrin-homology) were precipitated using anti-Flag antibodies (row 1). These complexes were probed for the presence of the endogenous catalytic subunit of PP2A using anti-PP2Ac antibodies (row 2). GEF-H1 and PP2Ac levels in cell lysates are shown (rows 3 and 4). ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5857 phospho 14-3-3-binding motif recognition antibody. Dephosphorylation of GEF-H1 at the 14-3-3 consensus sites by recombinant PP2Ac occurred within 10 min (Fig. 7a) , demonstrating that GEF-H1 can serve as a PP2A substrate. Together, these data demonstrate that GEF-H1 physically interacts with PP2A, which can dephosphorylate 14-3-3-binding sites in vitro. Since the inhibited state of GEF-H1 is associated with phosphorylation of the driver 14-3-3 site Ser885, and mutation of this site (Ser885A) causes constitutive activation of GEF-H1 (ref. 6), we wanted to determine whether thrombin treatment specifically induced dephosphorylation of Ser885. Starved cells were treated with thrombin and cells were lysed over a time course of 45 min, and immunoblotted with a phospho-Ser885-specific GEF-H1 antibody. Ser885 phosphorylation was detected in starved cells, but decreased after 5 min of thrombin treatment (Fig. 7b) . GEF-H1 dephosphorylation at Ser885 was transient, with the return of phosphorylation by 10 min, suggesting that GEF-H1 is active for only a brief period of time.
We then examined whether the interaction between PP2A subunits and GEF-H1 increased in response to thrombin treatment, and whether the kinetics of the interaction correlated with the transient dephosphorylation of Ser885. Starved HEK293T cells expressing Flag-tagged PPP2R5E B 0 subunit were treated with thrombin and lysed at different time points. Flag-PPP2R5E B 0 immunoprecipitates were probed for endogenous GEF-H1. We observed a switch-like induction of GEF-H1 association with the B 0 subunit at 5 min following thrombin treatment (Fig. 7c) . This interaction was reduced at 10 min and was undetectable after 20 min of thrombin treatment (Fig. 7c) . The GEF-H1:PP2A interaction was anti-correlated with Ser885 phosphorylation (Fig. 7c, third panel) , with the protein complex assembling to its maximum at 5 min following thrombin treatment and decreasing towards baseline thereafter. We observed similar kinetics in the interaction between GEF-H1 and the endogenous PP2A catalytic subunit following thrombin treatment (Fig. 7d) . Importantly, the levels of GEF-H1 associated with the microtubule dynein complex, as measured by the association of GEF-H1 with Tctex-1, decreased in response to thrombin (Fig. 7d) . These results show that PP2A and GEF-H1 form a dynamic complex in response to thrombin, which is temporally correlated to dephosphorylation of the GEF-H1 negative regulatory site Ser885, loss of dynein interaction and redistribution from the microtubule array.
Microtubule depolymerization-independent GEF-H1 activation.
Our results suggest a model where GEF-H1 activation results from disruption of the GEF-H1:dynein complex by G-protein subunits in the absence of microtubule depolymerization 6, 7 . To test this model, we next determined whether Taxol-induced stabilization of microtubules could inhibit LPA or thrombin-mediated activation of GEF-H1. We measured the effect of Taxol on GPCR-mediated GEF-H1 dephosphorylation, stress fibre formation and GEF activation. Starved HEK293T cells were pre-treated with Taxol and then stimulated with thrombin. Lysates were recovered at different time intervals and probed for the levels of GEF-H1 pSer885. We found that Taxol did not affect the kinetics or the magnitude of thrombin-induced GEF-H1 dephosphorylation compared with untreated control cells (Fig. 8a) . Similarly, we examined whether Taxol could suppress LPA or thrombininduced GEF-H1 redistribution from the microtubule array and stress fibre formation. GEF-H1 knockout MEFs were transfected with GEF-H1-eGFP, starved for 3 days, exposed to Taxol and visualized by confocal microscopy after LPA or thrombin treatment. Pretreatment of cells with Taxol failed to suppress LPA or thrombin-stimulated GEF-H1 redistribution from the microtubule to the cytoplasm and the formation of stress fibres (Fig. 8b,d ). To ensure that the microtubules were not undergoing (Fig. 8c) . Moreover, the microtubule stabilizing effect of Taxol could not antagonize activation of GEF-H1 by LPA or thrombin ( Fig. 8e;  Supplementary Fig. 5 ). These data provide evidence that GPCRmediated activation of GEF-H1 does not require disassembly of the microtubule array. Since the microtubule-depolymerizing agent nocodazole activates GEF-H1 by direct microtubule depolarization (Fig. 8b , third row and Fig. 8e ), we investigated whether pretreatment of cells with Taxol could suppress this effect. We observed that pretreatment with Taxol prior to exposure to nocodazole blocked the ability of nocodazole to stimulate both stress fibre formation (Fig. 8b) and GEF-H1 activation (Fig. 8e) .
Discussion
We report here a multistep mechanism for GPCR-mediated activation of the RhoGEF GEF-H1. We show that both Ga and Gbg subunits operate in a concerted manner to activate GEF-H1 through its displacement from the microtubule array, where it is anchored in an inhibited state by the dynein motor light-chain Tctex-1. In addition, we have discovered that following thrombin stimulation, the PP2A phosphatase associates with GEF-H1 and dephosphorylates the negative regulatory 14-3-3-binding site, Ser885.
RhoGEFs are activated by G-protein subunits through a variety of different mechanisms 13 . For example, Ga 12/13 subunits activate p115-RhoGEF, LARG and PDZ-RhoGEF 18 , Gaq/11 activates p63RhoGEF and TrioC, whereas Gbg can directly bind and activate P-Rex1 and P-Rex2, p114RhoGEF and Arhgef5 (refs 13,22) . Ga 12/13 subunits bind to their target proteins through a conserved domain called the RGS. There are over 39 mammalian RGS-and RH-domain-containing proteins ranging from small proteins comprised solely of an RGS domain to multi-domain proteins, which serve as scaffolds to diversify downstream signalling events. The canonical RGS domain consists of a nine-a-helix bundle, which in some instances can stabilize the Ga 12/13 transition state required to accelerate the hydrolysis of GTP, which inactivates Ga thus controlling the longevity of G-protein signalling [23] [24] [25] [26] . The RhoGEFs p115-RhoGEF, LARG and PDZ-RhoGEF bind to Ga 12/13 subunits through a RH domain 27 contained in their peptide sequence. The RH domains of the p115RhoGEF 28 and the PDZ-RhoGEF 29 share a conserved core with the RGS domain, but possess additional N-and C-terminal extensions that mediate a distinct mode of interaction with Ga. Ga 12/13 localizes GEFs to the plasma membrane or stimulates GEF activity directly through the release of an autoinhibitory domain or both 18, [30] [31] [32] [33] .
GEF-H1 lacks a canonical RGS domain, nevertheless, in this study, we have shown that active Ga 12/13 binds to a region encompassing the first 240 amino acids of GEF-H1 and stimulates its intrinsic exchange activity. We carefully examined whether this region of GEF-H1 shares any structural features of a RH domain, however, the N terminus of GEF-H1 cannot be aligned with RH-containing sequences present in PDZ-RhoGEF and p115-RhoGEF. Furthermore, the DISOPRED algorithm 34 predicts that this region is intrinsically disordered except for residues 40-85, which comprise a conserved C1 domain predicted to form a zinc-finger-like structure. Furthermore, GEF-H1 lacks the IIG and EDF/YD/E motifs that typify the RH domains present in other RhoGEFs. Our pull-down data (Fig. 4a,b) indicated that residues 1-87 (which include the C1 domain) bind Ga weakly, whereas residues 87-985 bind Ga almost as well as 1-985. These results strongly argue that Ga binding to GEF-H1 involves an intrinsically disordered region in the N-terminal portion of GEF-H1, which may undergo binding-coupled folding. Such proteinprotein interactions involving intrinsically disordered regions have been seen in many signalling proteins and transcription factors 35 . More comprehensive understanding of this unique mode of Ga interaction awaits further structural studies to elucidate the detailed binding interface of GEF-H1 and Ga 12/13 .
We have demonstrated that the consequences of Ga binding to GEF-H1 include displacement of GEF-H1 from the microtubule array. This effect is most likely a direct result of competitive binding between Ga 12/13 and Tctex-1, since they share an overlapping binding site within the N terminus of GEF-H1. Ga 12/13 activates GEF-H1 first by displacing GEF-H1 from the microtubule-associated inhibited sink, however, it is possible that Ga 12/13 binding to the N terminus of GEF-H1 might also relieve a potential negative regulatory mechanism in a manner similar to the regulation of the RH-family of GEFs.
In addition to the action of Ga, we have shown Gbg subunits activate GEF-H1 by targeting the Tctex-1:DIC-binding interface. Tctex-1 was found to bind to Gbg subunits in a functional genetic screen looking for receptor-independent activators of G-proteins called activator of G-protein signalling 14 . In a subsequent study, Sachdev et al. 15 found that Gbg binds to a dynein-free cytoplasmic fraction of Tctex-1. They showed that Gb competes with the DIC to displace Tctex-1 from the dynein motor complex. Our data demonstrate that Gbg subunits operating downstream of thrombin or LPA receptors dispace and activate GEF-H1 through a similar mechanism. We propose that free Gbg subunits bind to Tctex-1, resulting in the displacement of Tctex-1 and GEF-H1 from DIC and the dynein complex. Therefore, both Ga and Gbg collaborate to disrupt the GEF-H1:Tctex-1:DIC inhibited complex by competing with the GEF-H1:Tctex-1 and Tctex-1:DIC interfaces, respectively. To our knowledge, this is the first report of a system in which both the Ga and Gb subunits signal to activate a pathway by engaging distinct components of the same complex.
Nocodozole-induced microtubule depolymerization potently activates GEF-H1 (refs 5-7), thus GEF-H1 activity during mitosis may be a consequence of the change in microtubule dynamics during the reorganization of stable interphase microtubules into the mitotic spindle 36 . Our data demonstrate that GEF-H1 can be activated in interphase through a second mechanism that is independent of microtubule disassembly. We show that LPA or thrombin treatment leads to the acute relocalization of GEF-H1 off the microtubule array without evidence of microtubule disruption. Whereas Taxol suppressed the effects of nocodazolemediated microtubule depolymerization and GEF-H1 activation, it had no effect on inhibiting LPA-or thrombin-mediated microtubule relocalization or activation of GEF-H1. Therefore, disruption of the GEF-H1:Tctex-1-inhibited complex following LPA treatment by the concerted actions of Ga and Gbg are sufficient to activate GEF-H1 in the absence of microtubule depolymerization. A similar phenomenon has recently been reported where the activation of GEF-H1 following the application of tensional force on cells was independent of microtubule depolymerization 10 . Thrombin-induced partial depolymerization of microtubules has been described in endothelial cells 2 . We observed such partial depolymerization of microtubules in response to thrombin treatment only at time points after GEF-H1 had already been released from the microtubules. Moreover, blocking this depolymerization by Taxol did not prevent GEF-H1 relocalization. Interestingly, GEF-H1 displacement from microtubules may contribute to microtubule depolymerization in response to thrombin, as GEF-H1 has been reported to promote microtubule stability 37 .
GEF-H1's activity in normal cells is tightly regulated through phosphorylation 3, 7, 21, 38 . In a previous publication, we found that PKA phosphorylates and inhibits GEF-H1 by creating a 14-3-3-binding site 3 , which strongly suggests that a cellular phosphatase(s) is involved in the activation of GEF-H1. In this study, we provide evidence that the PP2A phosphatase positively regulates GEF-H1 by dephosphorylating Ser885. We show that GEF-H1 associates with the catalytic (C), scaffold (A) and B 0 regulatory subunits of the PP2A heterotrimer in cells, and that the recombinant PP2A catalytic subunit was competent to dephosphorylate the 14-3-3-binding site on GEF-H1 in vitro. Moreover, we demonstrated that activation of cells with either thrombin or LPA induced a transient GEF-H1:PP2A interaction that was temporally correlated with both dephosphorylation of Ser885 and stress fibre formation. The precise mechanisms by which G-protein subunits trigger the assembly of GEF-H1 with PP2A remain to be established.
In summary, we describe a novel multistep process by which the RhoGEF GEF-H1 is activated downstream of GPCR stimulation. We show that G-protein subunits engage in the disassembly of the GEF-H1:Tctex-1:DIC complex, which tethers GEF-H1 locked in an inhibited state to polymerized microtubules. The displacement of GEF-H1 from the microtubule array corresponds with its assembly with PP2A phosphatase subunits required for the dephosphorylation of a negative regulatory 14-3-3-binding site in the carboxyterminus of GEF-H1. We conjecture that the multiple molecular events required for GEF-H1 activation has evolved as a mechanism to ensure a highly restricted temporal and spatial activation of the Rho pathway downstream of GPCR ligand stimulation.
Methods
Expression constructs. Full-length GEF-H1 (accession no. AF177032) or truncated versions (as described in the figures) were cloned into the pFlag-CMV2 vector (Sigma). Complementary DNAs for all full-length and truncated versions of GEF-H1 and D87-151GEF-H1 were cloned into pcDNA3.1-His/Myc vector (Invitrogen). eGFP-tagged GEF-H1 and Tctex-1 were constructed by cloning fulllength GEF-H1 or Tctex-1 (accession no. NM_174620) into peGFP-C1 (Invitrogen). GEF-H1, D151GEF-H1 and Tctex-1 were cloned into the BglII/AgeI and BglII/EagI sites of pCMV-HA-VC155 and pCMV-HAVN173, respectively.
Cell culture and transfection. MEFs derived from GEF-H1 À / À (ref. 6) or wildtype littermate embryos and HEK293T cells were cultured in Dulbecco's modified Eagle's medium (DMEM, Life Technologies Inc.) supplemented with 10% fetal bovine serum (FBS) (HyClone). MEFs and Rat2 cells were transfected using Effectene (QIAGEN), and HEK293T using Polyfect, according to the manufacturer's instructions. All cultures were maintained in a 5% CO 2 environment at 37°C. For cell spreading and attachment analyses, cells were propagated at low passage number in the presence of DMEM with 10% FBS.
Antibodies. Rabbit anti-DYNLT1 antibody (anti-Tctex-1) was purchased from Proteintec (11954-1-ap). Polyclonal sheep anti-GEF-H1 antibodies were described previously 36 Immunofluorescence imaging. Cells grown on glass coverslips were treated as indicated in the corresponding figure legends and fixed with 4% paraformaldehyde for 10 min, washed three times with phosphate-buffered saline (PBS) and permeabilized with 0.1% Triton-X-100 for 5 min. The coverslips were blocked with 0.5% w/v bovine serum albumin (BSA) in PBS for 1 h at room temperature and incubated with primary antibody (anti-DYNLT1 1:400, sheep anti-GEF-H1 1:150, anti-tubulin 1:300 and anti-vinculin 1:400) or Texas Red phalloidin (1:400) in 0.5% BSA/PBS at 37°C for 30 min or at 4°C overnight. Coverslips were washed three times with PBS and incubated with secondary antibody (1:500) at 37°C for 1 h. For double labelling, slides were stained sequentially with primary and secondary antibodies at 37°C for 30 min, followed by 4 0 ,6-diamidino-2-phenylindole (Molecular Probes, Invitrogen) to stain nuclei. Slides were mounted using GelTol mounting medium (Shandon Immunon, Thermo Electron Corporation). Confocal imaging was performed with an Olympus IX81 inverted microscope using a Â 60 zoom Â 3(1.4 NA; PlanApo, Nikon) objective, and FluoView software (Olympus, Tokyo, Japan). Resolution was 512 Â 512 with 12 bits per pixel. Excitation wavelengths used for GFP, Texas Red, 4 0 ,6-diamidino-2-phenylindole or Pacific Blue were 473, 559, 358 and 405 nm, respectively. All images in each set of experiments were acquired with the same microscope sensitivity settings. All images compared within each figure panel were acquired on the same day, with identical staining conditions, gain and contrast setting, and same magnification (except Fig. 1c) . All statistical analyses were derived from 60 or more images from three independent experiments for each treatment condition.
NMR-based GEF assay. To measure GEF activity in lysates of mammalian cells, real-time NMR GEF assays were performed 6, 17 . Nucleotide exchange assays were carried out at 20°C with 0.4 mM 15 N-labelled RhoA (residues 1-181) in NMR buffer (20 mM HEPES, 100 mM NaCl, 5 mM MgCl 2 , 2 mM Tris (2-carboxyethyl) phosphine, 10% D 2 O, pH 7.0) using a Bruker 600 MHz NMR spectrometer equipped with a 1.7-mm microcryoprobe. Successive 1 H-15 N-HSQC spectra (4 scans, 10 min per spectrum) were collected and seven pairs of guanosine diphosphate (GDP)/GTPgS-specific peaks (V9, Q29, A56, S73, D87, T163 and W158) were used to determine the fraction of GDP-bound RhoA in each spectrum ( Supplementary Fig. 6 ). Data were fitted to a single-phase exponential decay function to obtain the exchange rate. HEK293T cells were transfected with the indicated constructs for 48 h, and the GEF activity in lysates was measured by harvesting cells in a minimal volume (for example, 150 ml for a 6-cm plate) of lysis buffer (1% Triton-X, 10% glycerol, 50 mM HEPES pH 7.5, and Complete Protease Inhibitor cocktail (Roche)) to achieve high total protein concentration (B10 mg ml À 1 ). All cell lysates were freshly prepared immediately before performing assays, and partially clarified by centrifugation (16,000g, 30 s). The amount of GEF-H1 in each assay was standardized by eGFP fluorescence of the lysate measured by a Shimadzu RF-5301PC spectrofluorophotometer. To compare endogenous cellular GEF activity, total cellular protein in lysates was standardized using the Bradford assay. To initiate nucleotide exchange, 2 mM GTPgS and lysate were added to 15 N RhoA-GDP. Intrinsic RhoA nucleotide exchange was measured by adding lysis buffer. Where indicated, HEK293 cells were treated prior to harvesting as follows: nocodazole (20 mM, 10 min), Taxol (10 mM), LPA (1 mM, 30 min) and thrombin (3 U ml À 1 , 1 h).
Image analysis. Image analysis for co-localization was performed with the cell profiler v2.0 1 using the 'MeasureCorrelation' module for correlation. Focal adhesion counts were performed using ImageJ v1.4q 2 (http://rsb.info.nih.gov/ij/ index.html). Vinculin-stained cell images were transformed to 16 bits and the background was subtracted using the 'background subtractor' plugin 3. Then they were transformed into binary images and focal adhesions were identified using the find maxima tool (Noise tolerance of 20). Paired Student's t-tests (ref. 39 ) were performed to determine statistical significance between samples. Experiments were performed at least three times, and means with Po0.05 were considered statistically significant. The correlation coefficient (R) measuring co-localization was determined from three independent experiments. Error bars represent s.d. of at least three independent replicates, and P values derived from pairwise t-tests are indicated.
Full-length GEF-H1 expression and purification protocol. Full-length GEF-H1 with a His 6 tag and an N-terminal immunoglobulin-binding protein (BiP) secretion signal sequence was expressed in Drosophila S2 cells using the pMTTEVA vector 6 . S2 cells were cultured in serum-free media and induced with 6 mM CdCl 2 at a density of 5 Â 10 6 cells per ml for 4 days. GEF-H1 was captured with Ni 2 þ -NTA resin and further purified by anion-exchange (HiTrap Q) and size-exclusion chromatography (Superdex 200). Purified recombinant Ga 13 was a kind gift from P. Sternweis (UT Southwestern Medical Center).
Cell treatments. Cells were starved for 5 days in the absence of serum and treated in DMEM containing 20 mM HEPES and 0.5 mg ml À 1 fatty acid-free BSA (A8806, Sigma). LPA obtained from Sigma (7260) was suspended in Hank's buffered saline solution containing 0.5 mg ml À 1 fatty acid-free BSA and 20 mM HEPES to a stock concentration of 1 mM. Cells were treated with 1 mM LPA for 30 min or as indicated in the figures. Bovine thrombin (605157) was purchased from Calbiochem and reconstituted to a concentration of 1 U ml À 1 . Cells were treated with 3 U ml À 1 thrombin for 1 h or as indicated in the figures.
Proteomics analyses. Flp-In T-Rex 293 cells (Invitrogen) were stably transfected with N-terminally-FLAG-tagged PP2A constructs and protein expression was induced by tetracycline addition. FLAG-tagged proteins and their putative interaction partners were recovered by immunoprecipitation on anti-FLAG magnetic beads 40 .
Mass spectroscopy. Samples digested on beads were acidified and loaded onto home-packed C18 capillary columns (75 mm inner diameter). HPLC columns were placed in-line in front of an LTQ mass spectrometer (Thermo) equipped with a Nanosource (Proxeon) for data-dependent acquisition over a 2-h acetonitrile 2-40% gradient 41 . Acquired RAW files were converted to mgf format using ProteoWizard 42 , and searched with the Mascot search engine (Matrix Science, London, UK, version 2.3.02) against the human RefSeq database supplemented with the RefSeq adenovirus entries (release 45) with a precursor ion mass tolerance of 3.0 and a fragment ion mass tolerance of 0.6. Methionine oxidation and asparagine deamidation were allowed as variable modifications, and trypsin specificity (with one missed cleavage allowed) was selected. The data were analysed in the 'Analyst' module of ProHits 43 and exported into Excel files for spectral normalization and manual extraction of the data corresponding to GEF-H1 and PPP2R1A (the remainder of the data set will be the topic of a separate publication). Two biological replicates analyses were performed on each of the baits. Fourteen negative control runs were also performed that consisted of cells expressing the FLAG tag fused to a green fluorescent protein. Importantly, GEF-H1 was not identified in any of the negative control runs.
Phosphatase assays. For dephosphorylation of GEF-H1 immunoprecipitates with PP2A, cells were lysed in phosphatase lysis buffer (50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA pH 8, 1% v/v NP40, 1 mM dithiothreitol, 1 mM phenylsulfonylfluoride with Complete Protease Inhibitor cocktail (Roche)), and immunoprecipitates were washed twice with lysis buffer then three times with PP2A phosphatase buffer (20 mM HEPES pH 8, 1 mM dithiothreitol and 1 mM MnCl 2 ). Beads were preheated with 100 ml PP2A phosphatase buffer for 10 min at 30°C prior to the addition of 0.1 U PP2A (Upstate, 14-111) and incubation at 30°C. Reactions were stopped by washing beads with lysis buffer containing phosphatase inhibitors and boiling beads for 10 min in 2 Â sample buffer prior to SDS-polyacrylamide gel electrophoresis. 
